This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.
Submitted: ; Accepted: ; Published: .
Erre GL, Mangoni AA. Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue. Drugs in Context 2021; 10: 2020-12-1. DOI: 10.7573/dic.2020-12-1
Copyright © 2021 Erre GL, Mangoni AA. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.
| Source | HTML views | PDF downloads | Totals |
|---|---|---|---|
| Drugs in Context since September 15, 2025 | 10 | 0 | 10 |
| PubMed Central since November 1, 2024 | 28 | 7 | 35 |
| Totals | 38 | 7 | 45 |